Blood Transfusion Diagnostics Market: By Technology, By Product Type, By Application, By End User, and Region Forecast 2020-2031
Blood Transfusion Diagnostics Market size was valued at US$ 6.09 billion in 2024 and is expected to reach US$ 9.85 billion by 2031, growing at a significant CAGR of 7.1% from 2025-2031. Blood transfusion is a medical procedure in which the blood is donated to the patient through a narrow tube that is placed within the vein. The blood transfusion is a life-saving procedure which helps in replacing the blood loss during surgery or injury. The transfusion process is done even if the patient's body is not capable of make blood owing to illness. With blood transfusion process, blood products like red blood cells, white blood cells, platelets and others are transfused to the patient.
The blood transfusion diagnostics play a vital role in the blood transfusion which reduces the chance of infection. In June 2017, Grifols has launched Erytra Eflexis, the latest advancement in scalable blood typing solutions which can adapt to different laboratory workflow. Blood transfusion is the intravenous transfer of blood or blood products. Blood transfusions can be used to replace blood components that have been lost. The most common blood components transfused include red blood cells, white blood cells, platelets, clotting factors, and plasma.
During an emergency or a serious case of massive blood loss, these blood components are crucial to laboratories and hospitals. When haemoglobin levels fall below 100g/L, RBC transfusion is required. Before being transfused, blood from a donor must be checked for a variety of infectious diseases. As a result, blood transfusion diagnostics play a vital role in preventing infection in both the recipient and the healthcare workers.
Study Period
2025-2031Base Year
2024CAGR
7.1%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The development in the technology is a key factor attributing to the growth of the market. The growing blood transfusion procedures and increasing prevalence of infectious diseases are anticipated to drive the growth of the market. Increase in the awareness among the healthcare fraternity regarding the blood transfusion is likely to propel the growth of the market. The automation of the blood banks are adding fuel for the growth of the market. However, the risk involved in the transmission of the infectious diseases is likely to hinder the growth of the market.
Geographically, blood transfusion diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market is growing due to increase in the prevalence of blood related disorders. The higher awareness among the patient pool is likely to enhance the growth of the market in this region. The growing adoption of the nucleic acid amplification in the diagnosis of the blood and blood products is enriching the growth of the market.
The increasing adoption of the advanced treatment procedures is adding fuel for the growth of the market in this region. The Europe and the Asia Pacific regions fall next to that of the North America. The Asia Pacific market is expected to be the fastest growing market over the forecast period owing to its presence of large number of patient pool.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 6.09 billion |
|
Market Size in 2031 |
US$ 9.85 billion |
|
Market CAGR |
7.1% |
|
By Technology |
|
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The blood transfusion diagnostics market size was valued at US$ 6.09 billion in 2024 and is projected to grow at a CAGR of 7.1% from 2025 to 2031.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Asia Pacific is the fastest-growing region in the market.
| 1.Executive Summary |
| 2.Global Blood Transfusion Diagnostics Market Introduction |
| 2.1.Global Blood Transfusion Diagnostics Market - Taxonomy |
| 2.2.Global Blood Transfusion Diagnostics Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.Product Type |
| 2.2.3.Application |
| 2.2.4.End User |
| 2.2.5.Region |
| 3.Global Blood Transfusion Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Blood Transfusion Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Blood Transfusion Diagnostics Market By Technology, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. ELISA |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Nucleic Acid Amplification |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Rapid Test |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Real-Time PCR |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Fluorescence Assay |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Western Blot |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Blood Transfusion Diagnostics Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Platelets |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Red Blood Cells |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Albumin |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Blood Transfusion Diagnostics Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Disease Screening |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Blood Grouping |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Blood Transfusion Diagnostics Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Blood Banks |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Laboratories |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Blood Transfusion Diagnostics Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Blood Transfusion Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.ELISA |
| 10.1.2.Nucleic Acid Amplification |
| 10.1.3.Rapid Test |
| 10.1.4.Real-Time PCR |
| 10.1.5.Fluorescence Assay |
| 10.1.6.Western Blot |
| 10.2. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Platelets |
| 10.2.2.Red Blood Cells |
| 10.2.3.Albumin |
| 10.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Disease Screening |
| 10.3.2.Blood Grouping |
| 10.3.3.Others |
| 10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Blood Banks |
| 10.4.3.Diagnostic Laboratories |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Blood Transfusion Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.ELISA |
| 11.1.2.Nucleic Acid Amplification |
| 11.1.3.Rapid Test |
| 11.1.4.Real-Time PCR |
| 11.1.5.Fluorescence Assay |
| 11.1.6.Western Blot |
| 11.2. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Platelets |
| 11.2.2.Red Blood Cells |
| 11.2.3.Albumin |
| 11.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Disease Screening |
| 11.3.2.Blood Grouping |
| 11.3.3.Others |
| 11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Blood Banks |
| 11.4.3.Diagnostic Laboratories |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Blood Transfusion Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.ELISA |
| 12.1.2.Nucleic Acid Amplification |
| 12.1.3.Rapid Test |
| 12.1.4.Real-Time PCR |
| 12.1.5.Fluorescence Assay |
| 12.1.6.Western Blot |
| 12.2. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Platelets |
| 12.2.2.Red Blood Cells |
| 12.2.3.Albumin |
| 12.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Disease Screening |
| 12.3.2.Blood Grouping |
| 12.3.3.Others |
| 12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Blood Banks |
| 12.4.3.Diagnostic Laboratories |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Blood Transfusion Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.ELISA |
| 13.1.2.Nucleic Acid Amplification |
| 13.1.3.Rapid Test |
| 13.1.4.Real-Time PCR |
| 13.1.5.Fluorescence Assay |
| 13.1.6.Western Blot |
| 13.2. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Platelets |
| 13.2.2.Red Blood Cells |
| 13.2.3.Albumin |
| 13.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Disease Screening |
| 13.3.2.Blood Grouping |
| 13.3.3.Others |
| 13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Blood Banks |
| 13.4.3.Diagnostic Laboratories |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Blood Transfusion Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.ELISA |
| 14.1.2.Nucleic Acid Amplification |
| 14.1.3.Rapid Test |
| 14.1.4.Real-Time PCR |
| 14.1.5.Fluorescence Assay |
| 14.1.6.Western Blot |
| 14.2. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Platelets |
| 14.2.2.Red Blood Cells |
| 14.2.3.Albumin |
| 14.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Disease Screening |
| 14.3.2.Blood Grouping |
| 14.3.3.Others |
| 14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Blood Banks |
| 14.4.3.Diagnostic Laboratories |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Abbott Diagnostics (U.S) |
| 15.2.2.Novartis AG (Switzerland) |
| 15.2.3.Becton Dickinson (U.S) |
| 15.2.4.BAG healthcare (Germany) |
| 15.2.5.DiaSorin (Italy) |
| 15.2.6.Fujirebio (Belgium) |
| 15.2.7.Grifols (Spain) |
| 15.2.8.Siemens (Germany) |
| 15.2.9.Quidel (U.S) |
| 15.2.10.Hologic/Gen-Probe (U.S) |
| 15.2.11.Biokit (Spain) |
| 15.2.12.Bio-Rad (U.S) |
| 15.2.13.Beckman Coulter (U.S) |
| 15.2.14.Quotient Limited (U.S) |
| 15.2.15.Diagast (France) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
